» Articles » PMID: 8103994

Dopamine D2 Receptor Alteration in Patients with Periodic Movements in Sleep (nocturnal Myoclonus)

Overview
Specialties Neurology
Physiology
Date 1993 Jan 1
PMID 8103994
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Periodic movements in sleep (PMS) can cause severe sleep disturbances. We investigated the central dopamine D2 receptor density in patients with PMS with 123I-IBZM and single photon emission tomography (SPET). In PMS there was a lower 123I-IBZM binding in the basal ganglia compared to the control group. The results indicate a loss of central D2 receptors in PMS.

Citing Articles

Artificial Neural Networks Analysis of polysomnographic and clinical features in Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS): from sleep alteration to "Brain Fog".

Gagliano A, Puligheddu M, Ronzano N, Congiu P, Tanca M, Cursio I Nat Sci Sleep. 2021; 13:1209-1224.

PMID: 34326674 PMC: 8315772. DOI: 10.2147/NSS.S300818.


Searching for Novel Candidate Biomarkers of RLS in Blood by Proteomic Analysis.

Mondello S, Kobeissy F, Mechref Y, Zhao J, El Hayek S, Zibara K Nat Sci Sleep. 2021; 13:873-883.

PMID: 34234594 PMC: 8243594. DOI: 10.2147/NSS.S311801.


Respiratory-Related Leg Movements of Sleep Are Associated With Serotonergic Antidepressants But Not Bupropion.

McCall C, Winkelman J J Clin Sleep Med. 2018; 14(9):1569-1576.

PMID: 30176966 PMC: 6134249. DOI: 10.5664/jcsm.7338.


Neurophysiological mechanisms of circadian cognitive control in RLS patients - an EEG source localization study.

Zhang R, Brandt M, Schrempf W, Beste C, Stock A Neuroimage Clin. 2017; 15:644-652.

PMID: 28664035 PMC: 5480014. DOI: 10.1016/j.nicl.2017.06.018.


Brain imaging and networks in restless legs syndrome.

Rizzo G, Li X, Galantucci S, Filippi M, Cho Y Sleep Med. 2016; 31:39-48.

PMID: 27838239 PMC: 5846689. DOI: 10.1016/j.sleep.2016.07.018.


References
1.
Montplaisir J, Godbout R, Poirier G, Bedard M . Restless legs syndrome and periodic movements in sleep: physiopathology and treatment with L-dopa. Clin Neuropharmacol. 1986; 9(5):456-63. DOI: 10.1097/00002826-198610000-00006. View

2.
Dawson V, Dawson T, Filloux F, Wamsley J . Evidence for dopamine D-2 receptors on cholinergic interneurons in the rat caudate-putamen. Life Sci. 1988; 42(20):1933-9. DOI: 10.1016/0024-3205(88)90492-4. View

3.
Brucke T, Podreka I, Angelberger P, Wenger S, Topitz A, Kufferle B . Dopamine D2 receptor imaging with SPECT: studies in different neuropsychiatric disorders. J Cereb Blood Flow Metab. 1991; 11(2):220-8. DOI: 10.1038/jcbfm.1991.53. View

4.
Brodeur C, Montplaisir J, Godbout R, MARINIER R . Treatment of restless legs syndrome and periodic movements during sleep with L-dopa: a double-blind, controlled study. Neurology. 1988; 38(12):1845-8. DOI: 10.1212/wnl.38.12.1845. View

5.
Akpinar S . Treatment of restless legs syndrome with levodopa plus benserazide. Arch Neurol. 1982; 39(11):739. DOI: 10.1001/archneur.1982.00510230065027. View